首页> 外文期刊>Clinical and laboratory haematology >Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases.
【24h】

Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases.

机译:用FLAG-Ida条件化的微型同种异体移植物成功挽救RAEB / AML复发的早期同种异体移植物:两例报道。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Management options are often limited for patients with AML or high grade myelodysplasia (MDS) relapsing within a year of allogeneic transplantation. We report, in two such patients, the use of re-induction with FLAG-Ida chemotherapy, followed by the infusion of GCSF-mobilized blood stem cells from the same HLA-matched donor. Both patients achieved durable complete remissions with good quality of life and longer disease-free survival than after the first myeloablative allografts. This mini-allograft approach offers a practical, well-tolerated salvage and a potentially curative treatment for relapsed AML/high grade MDS patients failing a first conventional myeloablative allogeneic transplants.
机译:对于同种异体移植后一年内复发的AML或高度骨髓增生异常(MDS)复发的患者,管理选择常常受到限制。我们报道了在两名此类患者中,使用FLAG-Ida化疗进行再诱导,然后输注了来自同一HLA匹配供体的GCSF动员的血液干细胞。与第一次清髓同种异体移植术后相比,两名患者均获得了持久的完全缓解,生活质量良好,无病生存时间更长。这种微型同种异体移植方法为失败的复发性AML /高品位MDS患者提供了一种实用,耐受性良好的挽救方法,并且可能治愈了首例常规异基因同种异体移植失败的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号